Serotonergic dysfunction in patients with bipolar disorder assessed by the loudness dependence of the auditory evoked potential

Psychiatry Investigation

Volumn 9, Issue 3, 2012, Pages 298-306

  Lee, Kyung Sang ^a,b   Park, Young Min ^a,b   Lee, Seung Hwan ^a,b  

^a Inje University College of Medicine   (South Korea)

^b Clinical Emotion and Cognition Research Laboratory   (South Korea)

Author keywords

Bipolar disorder; LDAEP; Mood status; Serotonin

Indexed keywords

AMISULPRIDE; ARIPIPRAZOLE; BLONANSERIN; CARBAMAZEPINE; CHLORPROMAZINE; CLOZAPINE; LITHIUM; OLANZAPINE; PALIPERIDONE; QUETIAPINE; RISPERIDONE; VALPROIC ACID;

ADULT; ARTICLE; AUDITORY STIMULATION; BIPOLAR DEPRESSION; BIPOLAR DISORDER; BIPOLAR MANIA; CONTROLLED STUDY; DISEASE SEVERITY; EVOKED AUDITORY RESPONSE; FEMALE; HUMAN; LOUDNESS; LOUDNESS DEPENDENCE OF THE AUDITORY EVOKED POTENTIAL; MAJOR CLINICAL STUDY; MALE; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA; SEROTONINERGIC SYSTEM;

EID: 84866701202     PISSN: 17383684     EISSN: 19763026     Source Type: Journal    
DOI: 10.4306/pi.2012.9.3.298     Document Type: Article

References (53)

1. Hegerl U, Juckel G. Intensity dependence of auditory evoked potentials as an indicator of central serotonergic neurotransmission: a new hypothesis. Biol Psychiatry 1993;33:173-187.
2. Park YM, Kim DW, Kim S, Im CH, Lee SH. The loudness dependence of the auditory evoked potential (LDAEP) as a predictor of the response to escitalopram in patients with generalized anxiety disorder. Psycho-pharmacology (Berl) 2011;213:625-632.
3. Lee SH, Park GH. Psychophysiological Markers of Anxiety Disorders and Anxiety Symptoms. In: Kalinin V, Editor. Anxiety Disorders. Rijeka: InTech, 2011, p.203-226.
4. Salvadore G, Quiroz JA, Machado-Vieira R, Henter ID, Manji HK, Zarate CA Jr. The neurobiology of the switch process in bipolar disorder: a review. J Clin Psychiatry 2010;71:1488-1501.
5. Lee SH, Kim JH, Lee JH, Kim S, Park YM, Bae SM, et al. Aberrant response of selective serotonin reuptake inhibitor in two patients with high N100 amplitude slope. Korean J Psychopharmacol 2008;19:341-347.
6. Park YM, Lee SH, Park EJ. Usefulness of LDAEP to predict tolerability to SSRIs in major depressive disorder: a case report. Psychiatry Investig 2012;9:80-82.
7. Hegerl U, Ulrich G, Muller-Oerlinghausen B. Auditory evoked potentials and response to lithium prophylaxis. Pharmacopsychiatry 1987;20: 213-216.
8. Hegerl U, Wulff H, Muller-Oerlinghausen B. Intensity dependence of auditory evoked potentials and clinical response to prophylactic lithium medication: a replication study. Psychiatry Res 1992;44:181-190.
9. Rohayem J, Bayle JF, Richa S. Predictors of prophylactic response to lithium. Encephale 2008;34:394-399.
10. Hegerl U, Gallinat J, Juckel G. Event-related potentials. Do they reflect central serotonergic neurotransmission and do they predict clinical response to serotonin agonists? J Affect Disord 2001;62:93-100.
11. Mundo E, Walker M, Cate T, Macciardi F, Kennedy JL. The role of serotonin transporter protein gene in antidepressant-induced mania in bipolar disorder: preliminary findings. Arch Gen Psychiatry 2001;58: 539-544.
12. Rao JS, Kellom M, Reese EA, Rapoport SI, Kim HW. Dysregulated glutamate and dopamine transporters in postmortem frontal cortex from bipolar and schizophrenic patients. J Affect Disord 2012;136:63-71.
13. Dean B, Pavey G, McLeod M, Opeskin K, Keks N, Copolov D. A change in the density of [(3)H]flumazenil, but not [(3)H]muscimol binding, in Brodmann's Area 9 from subjects with bipolar disorder. J Affect Disord 2001;66:147-158.
14. Sun Y, Zhang L, Johnston NL, Torrey EF, Yolken RH. Serial analysis of gene expression in the frontal cortex of patients with bipolar disorder. Br J Psychiatry Suppl 2001;41:s137-s141.
15. Mahmood T, Silverstone T. Serotonin and bipolar disorder. J Affect Disord 2001;66:1-11.
16. Asberg M, Bertilsson L, Martensson B, Scalia-Tomba GP, Thoren P, Traskman-Bendz L. CSF monoamine metabolites in melancholia. Acta Psychiatr Scand 1984;69:201-219.
17. Swann AC, Secunda S, Davis JM, Robins E, Hanin I, Koslow SH, et al. CSF monoamine metabolites in mania. Am J Psychiatry 1983;140:396-400.
18. Thakore JH, O'Keane V, Dinan TG. d-fenfluramine-induced prolactin responses in mania: evidence for serotonergic subsensitivity. Am J Psychiatry 1996;153:1460-1463.
19. Nurnberger JI Jr, Berrettini W, Simmons-Alling S, Lawrence D, Brittain H. Blunted ACTH and cortisol response to afternoon tryptophan infusion in euthymic bipolar patients. Psychiatry Res 1990;31:57-67.
20. First MB, Spitzer RL, Gibbon M, Williams JBW. User's Guide for the Structured Clinical Interview for DSM-IV Axis I Disorders: Clinician Version (SCID-CV). Washington, DC:American Psychiatric Press; 1997.
21. First MB, Gibbon M, Spitzer RL, Williams JBW. User's Guide for the Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID-II). Washington, DC: American Psychiatric Press; 1997.
22. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-571.
23. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978;133:429-435.
24. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
25. Semlitsch HV, Anderer P, Schuster P, Presslich O. A solution for reliable and valid reduction of ocular artifacts, applied to the P300 ERP. Psycho-physiology 1986;23:695-703.
26. Gudlowski Y, Ozgurdal S, Witthaus H, Gallinat J, Hauser M, Winter C, et al. Serotonergic dysfunction in the prodromal, first-episode and chronic course of schizophrenia as assessed by the loudness dependence of auditory evoked activity. Schizophr Res 2009;109:141-147.
27. Pascual-Marqui RD. Standardized low-resolution brain electromagnetic tomography (sLORETA): technical details. Methods Find Exp Clin Pharmacol 2002;24(Suppl 4):5-12.
28. Fuchs M, Kastner J, Wagner M, Hawes S, Ebersole JS. A standardized boundary element method volume conductor model. Clin Neurophysiol 2002;113:702-712.
29. Brett M, Johnsrude IS, Owen AM. The problem of functional localization in the human brain. Nat Rev Neurosci 2002;3:243-249.
30. Mulert C, Juckel G, Augustin H, Hegerl U. Comparison between the analysis of the loudness dependency of the auditory N1/P2 component with LORETA and dipole source analysis in the prediction of treatment response to the selective serotonin reuptake inhibitor citalopram in major depression. Clin Neurophysiol 2002;113:1566-1572.
31. Cosgrove KP, Mazure CM, Staley JK. Evolving knowledge of sex differences in brain structure, function, and chemistry. Biol Psychiatry 2007;62:847-855.
32. Staley JK, Sanacora G, Tamagnan G, Maciejewski PK, Malison RT, Berman RM, et al. Sex differences in diencephalon serotonin transporter availability in major depression. Biol Psychiatry 2006;59:40-47.
33. Frey BN, Skelin I, Sakai Y, Nishikawa M, Diksic M. Gender differences in alpha-[(11)C]MTrp brain trapping, an index of serotonin synthesis, in medication-free individuals with major depressive disorder: a positron emission tomography study. Psychiatry Res 2010;183:157-166.
34. Park YM, Lee SH, Kim S, Bae SM. The loudness dependence of the auditory evoked potential (LDAEP) in schizophrenia, bipolar disorder, major depressive disorder, anxiety disorder, and healthy controls. Prog Neuropsychopharmacol Biol Psychiatry 2010;34:313-316.
35. Juckel G, Gallinat J, Riedel M, Sokullu S, Schulz C, Moller HJ, et al. Serotonergic dysfunction in schizophrenia assessed by the loudness dependence measure of primary auditory cortex evoked activity. Schizophr Res 2003;64:115-124.
36. Strauss ME, Bohannon WE, Stephens JH, Pauker NE. Perceptual span in schizophrenia and affective disorders. J Nerv Ment Dis 1984;172: 431-435.
37. Strauss ME, Prescott CA, Gutterman DF, Tune LE. Span of apprehension deficits in schizophrenia and mania. Schizophr Bull 1987;13:699-704.
38. Nasrallah HA, Tippin J, McCalley-Whitters M. Neurological soft signs in manic patients. A comparison with Schizophrenic and control groups. J Affect Disord 1983;5:45-50.
39. Malhi GS, Ivanovski B, Hadzi-Pavlovic D, Mitchell PB, Vieta E, Sachdev P. Neuropsychological deficits and functional impairment in bipolar depression, hypomania and euthymia. Bipolar Disord 2007;9:114-125.
40. Paradiso S, Lamberty GJ, Garvey MJ, Robinson RG. Cognitive impairment in the euthymic phase of chronic unipolar depression. J Nerv Ment Dis 1997;185:748-754.
41. van Gorp WG, Altshuler L, Theberge DC, Wilkins J, Dixon W. Cognitive impairment in euthymic bipolar patients with and without prior alcohol dependence. A preliminary study. Arch Gen Psychiatry 1998; 55:41-46.
42. Clark L, Kempton MJ, Scarna A, Grasby PM, Goodwin GM. Sustained attention-deficit confirmed in euthymic bipolar disorder but not in first-degree relatives of bipolar patients or euthymic unipolar depression. Biol Psychiatry 2005;57:183-187.
43. Ferrier IN, Stanton BR, Kelly TP, Scott J. Neuropsychological function in euthymic patients with bipolar disorder. Br J Psychiatry 1999;175: 246-251.
44. Hulvershorn LA, Karne H, Gunn AD, Hartwick SL, Wang Y, Hummer TA, et al. Neural activation during facial emotion processing in un-medicated bipolar depression, euthymia, and mania. Biol Psychiatry 2012;71:603-610.
45. Van der Schot A, Kahn R, Ramsey N, Nolen W, Vink M. Trait and state dependent functional impairments in bipolar disorder. Psychiatry Res 2010;184:135-142.
46. Blumberg HP, Leung HC, Skudlarski P, Lacadie CM, Fredericks CA, Harris BC, et al. A functional magnetic resonance imaging study of bipolar disorder: stateand trait-related dysfunction in ventral prefrontal cortices. Arch Gen Psychiatry 2003;60:601-609.
47. Simmons JG, Nathan PJ, Berger G, Allen NB. Chronic modulation of serotonergic neurotransmission with sertraline attenuates the loudness dependence of the auditory evoked potential in healthy participants. Psychopharmacology (Berl) 2011;217:101-110.
48. Hornung JP. The human raphe nuclei and the serotonergic system. J Chem Neuroanat 2003;26:331-343.
49. Matthews PR, Harrison PJ. A morphometric, immunohistochemical, and in situ hybridization study of the dorsal raphe nucleus in major depression, bipolar disorder, schizophrenia, and suicide. J Affect Disord 2012;137:125-134.
50. O'Neill BV, Croft RJ, Leung S, Guille V, Galloway M, Phan KL, et al. Dopamine receptor stimulation does not modulate the loudness dependence of the auditory evoked potential in humans. Psychopharmacology (Berl) 2006;188:92-99.
51. Hitz K, Heekeren K, Obermann C, Huber T, Juckel G, Kawohl W. Examination of the effect of acute levodopa administration on the loudness dependence of auditory evoked potentials (LDAEP) in humans. Psychopharmacology (Berl) 2012;221:389-396.
52. Guille V, Croft RJ, O'Neill BV, Illic S, Phan KL, Nathan PJ. An examination of acute changes in serotonergic neurotransmission using the loudness dependence measure of auditory cortex evoked activity: effects of citalopram, escitalopram and sertraline. Hum Psychopharmacol 2008;23:231-241.
53. Oliva J, Leung S, Croft RJ, O'Neill BV, O'Kane J, Stout J, et al. The loudness dependence auditory evoked potential is insensitive to acute changes in serotonergic and noradrenergic neurotransmission. Hum Psychopharmacol 2010;25:423-427.